Extensive discussion focused on who are the stakeholder for whom we want to collect data, what they are likely to be wanting to know and what key performance indicators will allow us to best capture such information. The outcomes of this initial discussion are presented in the table below. Stakeholder What do they want/need to know? At what level? ELIXIR trainers and Are we providing training which is effective and has impact volunteers To increase engagement from trainers and trainees For personal development / recognition ELIXIR leadership Is funding being invested appropriately? (HoN, SAB, IAB, Is there impact on ELIXIR services? Is training ● Hub) helping drive services’ development/usage? Impact on ELIXIR science/benefit for the ● organization as a whole ELIXIR users (life accessibility/acquisition of new skills - user ● scientists, perception of accessibility before and after training developers, medics, positive effect on research/practice/collaborations ● curators, industry, Uni, professional bodies, NGOs,....) National return on investment ● funders/RCs/policy who are we reaching? numbers, industry ● makers/ministries participation, ..... on research at the national level ● impact (number of publications) industry/health services practice ● engagement - skills transferability to Industry EU funders collaborations between member states/research ● infrastructures - community building interactions between less and more ● established countries; skills/knowledge transfer good practice distribution across EU ● perceived societal impact ● ELIXIR nodes (and similarity with national and ELIXIR leadership ● member benefit of ELIXIR membership (to/from) at national ● institutions) and local level General public, better use of resources/increased access ● taxpayers translation into practice/service enhancement
Extensive discussion focused on who are the stakeholder for whom we want to collect data, what they are likely to be wanting to know and what key performance indicators will allow us to best capture such information. The outcomes of this initial discussion are presented in the table below. Stakeholder What do they want/need to know? At what level? ELIXIR trainers and volunteers Are we providing training which is effective and has impact To increase engagement from trainers and trainees For personal development / recognition ELIXIR leadership (HoN, SAB, IAB, Hub) Is funding being invested appropriately? ● Is there impact on ELIXIR services? Is training helping drive services’ development/usage? ● Impact on ELIXIR science/benefit for the organization as a whole ELIXIR users (life scientists, developers, medics, curators, industry, Uni, professional bodies, NGOs,....) ● accessibility/acquisition of new skills - user perception of accessibility before and after training ● positive effect on research/practice/collaborations National funders/RCs/policy makers/ministries ● return on investment ● who are we reaching? numbers, industry participation, ..... ● impact on research at the national level (number of publications) ● industry/health services practice engagement - skills transferability to Industry EU funders ● collaborations between member states/research infrastructures - community building ● interactions between less and more established countries; skills/knowledge transfer ● good practice distribution across EU ● perceived societal impact ELIXIR nodes (and member institutions) ● similarity with national and ELIXIR leadership ● benefit of ELIXIR membership (to/from) at national and local level General public, taxpayers ● better use of resources/increased access translation into practice/service enhancement